Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, Hôpital Maisonneuve- Rosemont, Centre Intégré Universitaire de Santé et Services Sociaux de l'Est-de-l'île- de-Montréal, Montréal, Québec, Canada.
Faculté de Médecine, Université de Montréal, Montréal, Québec, Canada.
BMC Health Serv Res. 2024 Oct 18;24(1):1256. doi: 10.1186/s12913-024-11628-2.
Recently, our research team developed an open source and free website called the MEPP website (for the Mirror Effect Plus Protocol) to efficiently provide mirror therapy for patients with facial palsy. Previous studies demonstrated that the first version of the MEPP website improved user experience and likely optimized patients' performance during facial therapy. Nevertheless, compliance was found to be low despite a generally positive opinion of the website, and in light of our earlier findings, MEPP 2.0-a revised and enhanced version of the MEPP 0.1-was created. The purpose of this study was to examine and contrast various factors that help or impede institutional partners of the Quebec health care system from using the MEPP 2.0 website in comparison to its initial version.
Forty-one patients with facial palsy and nineteen clinicians working with this population were enrolled in a within-subject crossover study. For both the MEPP 1.0 and MEPP 2.0, user experience was assessed for all participants. Embodiment was assessed in patients, and factors influencing clinical use were assessed by clinicians. Qualitative comments about their experiences were also gathered. Descriptive statistics and reliability measures were calculated. Differences between the two MEPP versions were assessed using the linear mixed model.
Overall, patients appreciated more the MEPP 2.0 (OR = 4.57; p < 0.001), and all clinicians preferred the MEPP 2.0 over the MEPP 1.0. For patients, it seems that facial ownership, as well as possession and control of facial movements, was significantly better with the MEPP 2.0. For clinicians, the MEPP 2.0 specifically allowed them to self-evaluate their intervention and follow up with more objectivity. The use of the MEPP 2.0 was also modulated by what their patients reported. Qualitatively, options to access an Android app and needs for improving the exercises bank were mentioned as hindering factors.
The updated version of the MEPP website, the MEPP 2.0, was preferred by our different partners.
https://www.isrctn.com/ISRCTN10885397 . The trial was registered before the start of the study on the 1 December 2023.
最近，我们的研究团队开发了一个名为 MEPP 网站（用于镜像效应加协议）的开源免费网站，以有效地为面瘫患者提供镜像治疗。先前的研究表明，MEPP 网站的第一个版本提高了用户体验，并可能优化了患者在面部治疗期间的表现。然而，尽管网站得到了普遍的积极评价，但合规性却很低，鉴于我们之前的发现，我们创建了 MEPP 2.0——MEPP 0.1 的修订和增强版本。本研究旨在检查和对比各种因素，这些因素有助于或阻碍魁北克医疗保健系统的机构合作伙伴使用 MEPP 2.0 网站与其初始版本相比。
41 名面瘫患者和 19 名与该人群合作的临床医生参加了一项自身交叉研究。对于 MEPP 1.0 和 MEPP 2.0，所有参与者都评估了用户体验。在患者中评估了体现，在临床医生中评估了影响临床使用的因素。还收集了关于他们体验的定性意见。计算了描述性统计数据和可靠性度量。使用线性混合模型评估了两种 MEPP 版本之间的差异。
总体而言，患者更欣赏 MEPP 2.0（OR=4.57;p<0.001），所有临床医生都更喜欢 MEPP 2.0 而不是 MEPP 1.0。对于患者来说，似乎是面部所有权，以及对面部运动的拥有和控制，使用 MEPP 2.0 时明显更好。对于临床医生来说，MEPP 2.0 特别允许他们自我评估干预措施，并更客观地跟进。MEPP 2.0 的使用还受到患者报告的影响。从质上看，访问 Android 应用程序的选项和改善练习库的需求被认为是阻碍因素。
MEPP 网站的更新版本 MEPP 2.0 受到了我们不同合作伙伴的青睐。
https://www.isrctn.com/ISRCTN10885397。该试验于 2023 年 12 月 1 日开始前在 ISRCTN 注册。
